Warning letter
Interstate Blood Bank: warning letter of Jan 29, 2001
FDA warning letter UCM078240 · Minneapolis District Office
Key facts
| Reference number | UCM078240 |
|---|---|
| Company | Interstate Blood Bank |
| Subject | Current Good Manufacturing Practices for Blood and Blood Components |
| Issue date | Jan 29, 2001 |
| Posted date | Jan 29, 2001 |
| Issuing office | Minneapolis District Office |
| Product type | Biologics |
| CFR sections cited | 640, 606, 606.20, 606.20(b), 640.64(e), 606.100(b) |
| Country | 3 |
| Inspection city | Milwaukee |
| Inspection ZIP | 53204-2140 |
| Inspection start date | Nov 28, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: